Early antiretroviral treatment may preserve key immune responses to HIV

Investigators have found that instituting combination antiretroviral treatment at the earliest stages of HIV infection may allow the generation of functional CD8 ‘killer’ T cells and preservation of the CD4 helper T cells that are the virus’s primary target.
Source: Science Daily, https://www.sciencedaily.com